Cargando…
Emerging concepts in intestinal immune control of obesity-related metabolic disease
The intestinal immune system is an important modulator of glucose homeostasis and obesity-associated insulin resistance. Dietary factors, the intestinal microbiota and their metabolites shape intestinal immunity during obesity. The intestinal immune system in turn affects processes such as intestina...
Autores principales: | Khan, Saad, Luck, Helen, Winer, Shawn, Winer, Daniel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110751/ https://www.ncbi.nlm.nih.gov/pubmed/33972511 http://dx.doi.org/10.1038/s41467-021-22727-7 |
Ejemplares similares
-
Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity
por: Lin, Yi-Hsuan, et al.
Publicado: (2019) -
The Immune Landscape of Visceral Adipose Tissue During Obesity and Aging
por: Khan, Saad, et al.
Publicado: (2020) -
Gut-associated IgA(+) immune cells regulate obesity-related insulin resistance
por: Luck, Helen, et al.
Publicado: (2019) -
Normalization of Obesity-Associated Insulin Resistance through Immunotherapy: CD4+ T Cells Control Glucose Homeostasis
por: Winer, Shawn, et al.
Publicado: (2009) -
Regulation of the immune system by the insulin receptor in health and disease
por: Makhijani, Priya, et al.
Publicado: (2023)